{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:14:48Z","timestamp":1768565688446,"version":"3.49.0"},"reference-count":28,"publisher":"Impact Journals, LLC","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2014,6,30]]},"DOI":"10.18632\/oncotarget.2031","type":"journal-article","created":{"date-parts":[[2015,9,15]],"date-time":"2015-09-15T23:39:30Z","timestamp":1442360370000},"page":"4418-4425","source":"Crossref","is-referenced-by-count":50,"title":["Thymocyte selection-associated high mobility group box gene (TOX) is aberrantly over-expressed in mycosis fungoides and correlates with poor prognosis"],"prefix":"10.18632","volume":"5","author":[{"given":"Yuanshen","family":"Huang","sequence":"first","affiliation":[{"name":"Molecular Medicine Lab and Chieng Genomics Centre, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada"},{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"},{"name":"Terry Fox Laboratory, British Columbia Cancer Agency and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivan V.","family":"Litvinov","sequence":"additional","affiliation":[{"name":"Division of Dermatology, McGill University Health Center, Montreal, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Wan","family":"Su","sequence":"additional","affiliation":[{"name":"Molecular Medicine Lab and Chieng Genomics Centre, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada"},{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ping","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Venereology, Peking University First Hospital, Beijing, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoyan","family":"Jiang","sequence":"additional","affiliation":[{"name":"Terry Fox Laboratory, British Columbia Cancer Agency and Department of Medical Genetics, University of British Columbia, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas S.","family":"Kupper","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Brigham and Women's Hospital, Harvard Skin Disease Research Center, Harvard University, Boston, MA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan P.","family":"Dutz","sequence":"additional","affiliation":[{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"},{"name":"Dermatologic Oncology Program, British Columbia Cancer Agency, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Denis","family":"Sasseville","sequence":"additional","affiliation":[{"name":"Division of Dermatology, McGill University Health Center, Montreal, QC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Youwen","family":"Zhou","sequence":"additional","affiliation":[{"name":"Molecular Medicine Lab and Chieng Genomics Centre, Vancouver Coastal Health Research Institute, Vancouver, BC, Canada"},{"name":"Department of Dermatology and Skin Science, University of British Columbia, Vancouver, BC, Canada"},{"name":"Dermatologic Oncology Program, British Columbia Cancer Agency, Vancouver, BC, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2014,5,28]]},"reference":[{"issue":"7","key":"1","first-page":"854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Weinstock","year":"2007","journal-title":"Arch Dermatol"},{"issue":"19","key":"2","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1056\/NEJMra032810","article-title":"The pathogenesis of mycosis fungoides","volume":"350","author":"Wilson","year":"2004","journal-title":"N Engl J Med"},{"issue":"6","key":"3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.3816\/CLM.2009.n.081","article-title":"We should have a dream: unlocking the workings of the genome in cutaneous T-cell lymphomas","volume":"9","author":"Wong","year":"2009","journal-title":"Clin Lymphoma Myeloma"},{"issue":"10","key":"4","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1111\/j.1600-0560.2007.00924.x","article-title":"A genomic and expression study of AP-1 in primary cutaneous T-cell lymphoma: evidence for dysregulated expression of JUNB and JUND in MF and SS","volume":"35","author":"Whittaker","year":"2008","journal-title":"J Cutan Pathol"},{"issue":"6","key":"5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.jaad.2005.08.057","article-title":"Defining early mycosis fungoides","volume":"53","author":"Sander","year":"2005","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"6","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/00000372-200306000-00014","article-title":"Criterion by criterion, mycosis fungoides","volume":"25","author":"Glusac","year":"2003","journal-title":"Am J Dermatopathol"},{"issue":"6","key":"7","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Pittelkow","year":"2007","journal-title":"Blood"},{"issue":"2","key":"8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1177\/107327480701400203","article-title":"The diagnosis, staging, and treatment options for mycosis fungoides","volume":"14","author":"Glass","year":"2007","journal-title":"Cancer Control"},{"issue":"1","key":"9","first-page":"26","article-title":"Clinical characteristics and long-term outcome of patients with generalized patch and\/or plaque (T2) mycosis fungoides","volume":"135","author":"Hoppe","year":"1999","journal-title":"Arch Dermatol"},{"issue":"9","key":"10","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/archderm.1995.01690210033005","article-title":"Prognostic factors in erythrodermic mycosis fungoides and the Sezary syndrome","volume":"131","author":"Hoppe","year":"1995","journal-title":"Arch Dermatol"},{"issue":"6","key":"11","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2012.13","article-title":"Molecular markers of early-stage mycosis fungoides","volume":"132","author":"Zhou","year":"2012","journal-title":"J Invest Dermatol"},{"issue":"4","key":"12","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1038\/jid.2013.461","article-title":"miR-223 Regulates Cell Growth and Targets Proto-Oncogenes in Mycosis Fungoides\/Cutaneous T-Cell Lymphoma","volume":"134","author":"Eischen","year":"2014","journal-title":"J Invest Dermatol"},{"issue":"3","key":"13","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ni767","article-title":"TOX: an HMG box protein implicated in the regulation of thymocyte selection","volume":"3","author":"Kaye","year":"2002","journal-title":"Nat Immunol"},{"issue":"2","key":"14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.coi.2011.12.001","article-title":"The many roles of TOX in the immune system","volume":"24","author":"Kaye","year":"2012","journal-title":"Curr Opin Immunol"},{"issue":"1","key":"15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1084\/jem.20071944","article-title":"Development of all CD4 T lineages requires nuclear factor TOX","volume":"205","author":"Kaye","year":"2008","journal-title":"J Exp Med"},{"issue":"2","key":"16","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2340\/00015555-0197","article-title":"CD13 and TCR clone: markers of early mycosis fungoides","volume":"87","author":"Dreno","year":"2007","journal-title":"Acta Derm Venereol"},{"issue":"23","key":"17","doi-asserted-by":"crossref","first-page":"5896","DOI":"10.1182\/blood-2008-09-181024","article-title":"Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma","volume":"113","author":"Odum","year":"2009","journal-title":"Blood"},{"issue":"22","key":"18","doi-asserted-by":"crossref","first-page":"5891","DOI":"10.1182\/blood-2011-06-358382","article-title":"Diagnostic microRNA profiling in cutaneous T-cell lymphoma (CTCL)","volume":"118","author":"Mathiesen","year":"2011","journal-title":"Blood"},{"issue":"12","key":"19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1002\/gcc.20601","article-title":"Array-based comparative genomic hybridization in early-stage mycosis fungoides: recurrent deletion of tumor suppressor genes BCL7A, SMAC\/DIABLO, and RHOF","volume":"47","author":"Amerio","year":"2008","journal-title":"Genes Chromosomes Cancer"},{"issue":"3","key":"20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/10428194.2012.717695","article-title":"Loss of BCL7A expression correlates with poor disease prognosis in patients with early-stage cutaneous T-cell lymphoma","volume":"54","author":"Sasseville","year":"2013","journal-title":"Leuk Lymphoma"},{"issue":"12","key":"21","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/exd.12039","article-title":"The role of AHI1 and CDKN1C in cutaneous T-cell lymphoma progression","volume":"21","author":"Sasseville","year":"2012","journal-title":"Exp Dermatol"},{"issue":"6","key":"22","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1111\/j.1600-0625.2012.01489.x","article-title":"CD158k\/KIR3DL2 and NKp46 are frequently expressed in transformed mycosis fungoides","volume":"21","author":"Bensussan","year":"2012","journal-title":"Exp Dermatol"},{"issue":"9","key":"23","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1182\/blood.V100.9.3369","article-title":"Clonal heterogeneity in mycosis fungoides and its relationship to clinical course","volume":"100","author":"Jones","year":"2002","journal-title":"Blood"},{"issue":"1","key":"24","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome","volume":"113","author":"Tensen","year":"2009","journal-title":"Blood"},{"issue":"4","key":"25","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/jid.2009.306","article-title":"Oligonucleotide array-CGH identifies genomic subgroups and prognostic markers for tumor stage mycosis fungoides","volume":"130","author":"Ferreira","year":"2010","journal-title":"J Invest Dermatol"},{"issue":"8","key":"26","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1182\/blood-2006-12-061507","article-title":"Lesional gene expression profiling in cutaneous T-cell lymphoma reveals natural clusters associated with disease outcome","volume":"110","author":"Kupper","year":"2007","journal-title":"Blood"},{"issue":"7","key":"27","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1158\/1078-0432.CCR-09-2879","article-title":"Transcriptional profiles predict disease outcome in patients with cutaneous T-cell lymphoma","volume":"16","author":"Kupper","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"21","key":"28","doi-asserted-by":"crossref","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Rimm","year":"2004","journal-title":"Clin Cancer Res"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,13]],"date-time":"2020-05-13T19:50:18Z","timestamp":1589399418000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.2031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5,28]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,6,30]]}},"alternative-id":["2031","24947046"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.2031","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,5,28]]}}}